English Version of Clinical Practice Guidelines for the Management of Atopic Dermatitis 2021
-
- Hidehisa Saeki
- Department of Dermatology Nippon Medical School Tokyo Japan
-
- Yukihiro Ohya
- Allergy Center, National Center for Child Health and Development Tokyo Japan
-
- Junichi Furuta
- Medical Informatics and Management, Faculty of Medicine University of Tsukuba Tsukuba Japan
-
- Hirokazu Arakawa
- Kitakanto Allergy Research Institute Kibounoie Hospital Midori Japan
-
- Susumu Ichiyama
- Department of Dermatology Nippon Medical School Tokyo Japan
-
- Toshio Katsunuma
- Department of Pediatrics The Jikei University Daisan Hospital Tokyo Japan
-
- Norito Katoh
- Department of Dermatology Kyoto Prefectural University of Medicine Graduate School of Medical Science Kyoto Japan
-
- Akio Tanaka
- Department of Dermatology, Graduate School of Biomedical and Health Sciences Hiroshima University Hiroshima Japan
-
- Yuichiro Tsunemi
- Department of Dermatology Saitama Medical University Saitama Japan
-
- Takeshi Nakahara
- Department of Dermatology, Graduate School of Medical Sciences Kyushu University Fukuoka Japan
-
- Mizuho Nagao
- Allergy Center, National Hospital Organization Mie National Hospital Tsu Japan
-
- Masami Narita
- Department of Pediatrics, Faculty of Medicine Kyorin University Tokyo Japan
-
- Michihiro Hide
- Department of Dermatology, Graduate School of Biomedical and Health Sciences Hiroshima University Hiroshima Japan
-
- Takao Fujisawa
- Allergy Center, National Hospital Organization Mie National Hospital Tsu Japan
-
- Masaki Futamura
- Division of Pediatrics National Hospital Organization Nagoya Medical Center Nagoya Japan
-
- Koji Masuda
- Department of Dermatology Kyoto Prefectural University of Medicine Graduate School of Medical Science Kyoto Japan
-
- Tomoyo Matsubara
- Department of Pediatrics Dokkyo Medical University Saitama Medical Center Saitama Japan
-
- Hiroyuki Murota
- Department of Dermatology Nagasaki University Graduate School of Biomedical Sciences Nagasaki Japan
-
- Kiwako Yamamoto‐Hanada
- Allergy Center, National Center for Child Health and Development Tokyo Japan
この論文をさがす
抄録
<jats:title>Abstract</jats:title><jats:p>This is the English version of the Clinical Practice Guidelines for the Management of Atopic Dermatitis 2021. Atopic dermatitis (AD) is a disease characterized by relapsing eczema with pruritus as a primary lesion. In Japan, from the perspective of evidence‐based medicine, the current strategies for the treatment of AD consist of three primary measures: (i) use of topical corticosteroids, tacrolimus ointment, and delgocitinib ointment as the main treatment of the inflammation; (ii) topical application of emollients to treat the cutaneous barrier dysfunction; and (iii) avoidance of apparent exacerbating factors, psychological counseling, and advice about daily life. In the present revised guidelines, descriptions of three new drugs, namely, dupilumab, delgocitinib, and baricitinib, have been added. The guidelines present recommendations to review clinical research articles, evaluate the balance between the advantages and disadvantages of medical activities, and optimize medical activity‐related patient outcomes with respect to several important points requiring decision‐making in clinical practice.</jats:p>
収録刊行物
-
- The Journal of Dermatology
-
The Journal of Dermatology 49 (10), 2022-08-22
Wiley
- Tweet
キーワード
詳細情報
-
- CRID
- 1360017279866447744
-
- ISSN
- 13468138
- 03852407
-
- データソース種別
-
- Crossref
- KAKEN